| Institution: | 1. Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, 1030, Vienna, Austria;2. Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, 1030, Vienna, Austria;1. Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, State Key Laboratory of Genetic Engineering, Department of Biochemistry and Biophysics, School of Life Sciences, Shanghai Key Laboratory of Radiation Oncology, and Shanghai Key Laboratory of Medical Epigenetics, Shanghai Medical College of Fudan University, Shanghai 200032, China;2. The International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, China;3. Department of Systems Biology for Medicine, School of Basic Medical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China;4. Human Phenome Institute, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan University, Shanghai 200433, China;1. Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL 60637, USA;2. Department of Medicine, University of Chicago, Chicago, IL 60637, USA;3. 855 Jefferson Ave. Redwood City, CA 94063, USA;4. Department of Biochemistry & Molecular Biology, University of Chicago, Chicago, IL 60637, USA;5. Department of Human Genetics, University of Chicago, Chicago, IL 60637, USA;1. Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland;2. Swiss Centre for Applied Human Toxicology and Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland |
